TEMPLATE TREAT Registry report (TREAT Registry report)

TEMPLATE IDTREAT Registry report
ConceptTREAT Registry report
DescriptionT o record details of a TREAT registry report for Atopic Dermatitis.
PurposeT o record details of a TREAT registry report for Atopic Dermatitis.
References
Other Details (Language Independent)
  • MetaDataSet:Sample Set : Template metadata sample set
Language useden
Citeable Identifier1013.26.40
Root archetype idopenEHR-EHR-COMPOSITION.report.v1
TREAT Registry reportTREAT Registry report: Document to communicate information to others, commonly in response to a request from another party.
Other Context
PatientPatient: Identifiable details of a person compliant with European ISA standard.
Person IdentifierPerson Identifier: A unique personal identifier.
Person name (ISA)Person name (ISA): Personal name compliant with European ISA standard.
Family NameFamily Name: A family name is usually shared by members of a family. This attribute also carries prefixes or suffixes which are part of the Family Name, e.g. “de Boer”, “van de Putte”, “von und zu Orlow”.
Multiple family names, such as are commonly found in Hispanic countries, are recorded in the single Family Name field so that, for example, Miguel de Cervantes Saavedra's Family Name would be recorded as "de Cervantes Saavedra.
Given NameGiven Name: A given name, or multiple given names, are the denominator(s) that identify an individual within a family. These are given to a person by his or her parents at birth or may be legally recognised as 'given names' through a formal process.
All given names are ordered in one field so that, for example, the Given Name for Johan Sebastian Bach is 'Johan Sebastian.'
Anonymised person (PARENT)Anonymised person (PARENT): Anonymised details of a person.
Administrative GenderAdministrative Gender: Ther current administrative gender of the person.
  • Male 
  • Female 
  • Undetermined 
Death details (PARENT)Death details (PARENT): Details of person's death aligned with PARENT Common Data Elements for registry use.
Date of deathDate of death: The date of the subject's death.
Date of BirthDate of Birth: The person's date of birth.
Reporting professionalReporting professional: Details of a healthcare professional.
Person name (ISA)Person name (ISA): Personal name compliant with European ISA standard.
Full NameFull Name: The full name (fullName) property contains the complete name of a person as one string. In addition to the content of given name, family name and, in some systems, patronymic name, this can carry additional parts of a person’s name such as titles, middle names or suffixes like “the third” or names which are neither a given nor a family name.
Professional IdentifierProfessional Identifier: The healthcare worker's profesional identifier.
Healthcare provider (PARENT)Healthcare provider (PARENT): Details of a healthcare provider organisation.
Department nameDepartment name: The name of the organisation.
Hospital identifierHospital identifier: The unique identifier of the organisation.
Address (ISA)Address (ISA): Address details compliant with European ISA Standard.
Post Name (city)Post Name (city): The key postal division of the address, usually the city.
Admin Unit 2 (county/region/state)Admin Unit 2 (county/region/state): The region of the address, usually a county, state or other such area that typically encompasses several localities.
Admin Unit 1 (country)Admin Unit 1 (country): The uppermost administrative unit for the address, almost always a country.
Contact detailsContact details: Contact details for the organisation.
Contact detailsContact details: Contact details for the heathcare worker.
Relevant medical historyRelevant medical history: A generic section header which should be renamed in a template to suit a specific clinical context.
Problem/DiagnosisProblem/Diagnosis: An issue or obstacle which adversely impacts on the physical, mental and/or social well-being of an individual. The definition of a problem is deliberately kept rather loose and inclusive of a formal biomedical diagnosis so as to capture any real or perceived concerns that may adversely affect an individual's wellbeing to any degree.
Problem/DiagnosisProblem/Diagnosis: Identification of the index problem, issue or diagnosis.
Date of OnsetDate of Onset: The date / time when the problem was first identified by the individual.
Problem context qualifiersProblem context qualifiers: Additional status and contextual qualifiers factors related to a problem/diagnosis.
Active statusActive status: The degree to which the problem is active and relevant within the current clinical context.
  • Active 
  • Inactive 
  • Resolved 
  • In remission 
Current medicationCurrent medication: A generic section header which should be renamed in a template to suit a specific clinical context.
Medication orderMedication order: Details of a medicine, vaccine or other therapeutic good with instructions for use.
OrderOrder: The instructions for a particular medicine, vaccine or other therapeutic good including dose and timing.
Description
MedicineMedicine: The medicine, vaccine or other therapeutic good being ordered, administered to or used by the subject of care. This item should be coded if possible.
  •  Text
  •  Coded Text Value set: ac0001
Dose descriptionDose description: The amount and units of the medicine, vaccine or other therapeutic good to be used or administered at one time.
Timing descriptionTiming description: The timing of the doses, which may include frequency and details such as relationship to food.
Indication for authorised useIndication for authorised use: The specific indication for use that is required by an authorising agency to achieve subsidy for or access to the medicine, vaccine or other therapeutic good. This could be a national medication scheme, insurance company or other funding agency.
Medication Instruction IdMedication Instruction Id: An identifier used in an external system and associated with this medication instruction.
Concession benefitConcession benefit: Indicates the category of subsidy appropriate to the item being prescribed.
Physical examinationPhysical examination: A generic section header which should be renamed in a template to suit a specific clinical context.
Blood PressureBlood Pressure: The local measurement of arterial blood pressure which is a surrogate for arterial. pressure in the systemic circulation. Most commonly, use of the term 'blood pressure' refers to measurement of brachial artery pressure in the upper arm.
SystolicSystolic: Peak systemic arterial blood pressure - measured in systolic or contraction phase of the heart cycle.
0..1000 mmHg
DiastolicDiastolic: Minimum systemic arterial blood pressure - measured in the diastolic or relaxation phase of the heart cycle.
0..1000 mmHg
Height/LengthHeight/Length: Height, or body length, is measured from crown of head to sole of foot. Height is measured with the individual in a standing position and body length in a recumbent position.
Height/LengthHeight/Length: The length of the body from crown of head to sole of foot.
0..1000; 0..250
Units:
  • cm
  • in
CommentComment: Comment about the measurement of body height/length.
Body weightBody weight: Measurement of the body weight of an individual.
WeightWeight: The weight of the individual.
0..1000; 0..2000
Units:
  • kg
  • lb
Skin examinationSkin examination: Findings observed during the physical examination of a subject of care.
DescriptionDescription: Narrative description of the overall findings observed during a physical examination of a patient.
May be used to record a narrative summary of the complete clinical examination or key aspects of clinical examination findings, which will be supported by structured data. Details of specific structured findings can be included using CLUSTER archetypes in the 'Examination Detail' slot. This data element may be used to capture legacy data that is not available in a structured format.
Fitzpatrick skin typeFitzpatrick skin type: Numerical schema for classifying skin colour type based on reaction to ultraviolet radiation exposure.
Data
Skin typeSkin type: The Fitzpatrick Skin type.
  • 1: I 
  • 2: II 
  • 3: III 
  • 4: IV 
  • 5: V 
  • 6: VI 
Lymph nodesLymph nodes: Findings observed during the physical examination of a subject of care.
DescriptionDescription: Narrative description of the overall findings observed during a physical examination of a patient.
May be used to record a narrative summary of the complete clinical examination or key aspects of clinical examination findings, which will be supported by structured data. Details of specific structured findings can be included using CLUSTER archetypes in the 'Examination Detail' slot. This data element may be used to capture legacy data that is not available in a structured format.
Other examination findingsOther examination findings: Findings observed during the physical examination of a subject of care.
DescriptionDescription: Narrative description of the overall findings observed during a physical examination of a patient.
May be used to record a narrative summary of the complete clinical examination or key aspects of clinical examination findings, which will be supported by structured data. Details of specific structured findings can be included using CLUSTER archetypes in the 'Examination Detail' slot. This data element may be used to capture legacy data that is not available in a structured format.
Atopic dermatitis historyAtopic dermatitis history: A generic section header which should be renamed in a template to suit a specific clinical context.
Primary diagnosisPrimary diagnosis: An issue or obstacle which adversely impacts on the physical, mental and/or social well-being of an individual. The definition of a problem is deliberately kept rather loose and inclusive of a formal biomedical diagnosis so as to capture any real or perceived concerns that may adversely affect an individual's wellbeing to any degree.
Problem/DiagnosisProblem/Diagnosis: Identification of the index problem, issue or diagnosis.
Date of OnsetDate of Onset: The date / time when the problem was first identified by the individual.
Problem context qualifiersProblem context qualifiers: Additional status and contextual qualifiers factors related to a problem/diagnosis.
Active statusActive status: The degree to which the problem is active and relevant within the current clinical context.
  • Active 
  • Inactive 
  • Resolved 
  • In remission 
Previous treatmentsPrevious treatments: A generic section header which should be renamed in a template to suit a specific clinical context.
PhototherapyPhototherapy: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Phototherapy 
Default value: Phototherapy
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: false
Specific therapySpecific therapy: Details of specific therapies within a category.
Phototherapy typePhototherapy type: The type of phototherapy.
  • UVA-1 
  • NB-UVB 
Maximum doseMaximum dose: The maximum dose of phototherapy.
Cumulative doseCumulative dose: The cumulative dose of phototherapy.
Start dateStart date: The start date of the therapy.
Duration of therapyDuration of therapy: The duration of the therapy.
>=P0D
Units:
  • Year
  • Month
  • Week
  • Day
  • Hour
  • Minute
Frequency of therapyFrequency of therapy: The frequency of the therapy.
>=0; >=0
Units:
  • /d
  • /wk
  • /mo
  • /yr
  • {QUALIFIED REAL/TIME}
EffectivenessEffectiveness: An estimate of the effectivemess of the therapy.
  •  Coded Text
    • Good 
    • Moderate 
    • None (primary) 
    • None (secondary) 
  •  Text
Reason for stoppingReason for stopping: The reason for stopping the therapy.
  •  Coded Text
    • Sanata 
    • Adverse event 
    • Ineffective 
  •  Text
Systemic therapySystemic therapy: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Systemic therapy 
Default value: Systemic therapy
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: false
Specific therapySpecific therapy: Details of specific therapies within a category.
Sytemic therapy typeSytemic therapy type: The type of systemic therapy.
  •  Coded Text
    • Glucocorticosteroids 
    • CsA 
    • MTX 
    • AZA 
    • MMF 
    • MPS 
    • IVIG 
  •  Text
RouteRoute: The systemic therapy route.
  • Oral 
  • Intramuscular 
  • Intravenous 
Start dateStart date: The start date of the therapy.
Duration of therapyDuration of therapy: The duration of the therapy.
>=P0D
Units:
  • Year
  • Month
  • Week
  • Day
  • Hour
  • Minute
Frequency of therapyFrequency of therapy: The frequency of the therapy.
>=0; >=0
Units:
  • /d
  • /wk
  • /mo
  • /yr
  • {QUALIFIED REAL/TIME}
EffectivenessEffectiveness: An estimate of the effectivemess of the therapy.
  •  Coded Text
    • Good 
    • Moderate 
    • None (primary) 
    • None (secondary) 
  •  Text
Reason for stoppingReason for stopping: The reason for stopping the therapy.
  •  Coded Text
    • Sanata 
    • Adverse event 
    • Ineffective 
  •  Text
Daycare treatmentDaycare treatment: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Daycare treatment 
Default value: Daycare treatment
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: false
Specific therapySpecific therapy: Details of specific therapies within a category.
Number of treatmentsNumber of treatments: The total number of treatments.
>=0
HospitalisationHospitalisation: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Hospitalisation 
Default value: Hospitalisation
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: false
Specific therapySpecific therapy: Details of specific therapies within a category.
Reason for hospitalisationReason for hospitalisation: The reason for hospitalisation.
Number of admissionsNumber of admissions: The total number of treatments.
>=0
Current Atopic dermatitis therapyCurrent Atopic dermatitis therapy: A generic section header which should be renamed in a template to suit a specific clinical context.
Systemic therapySystemic therapy: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Systemic therapy 
Default value: Systemic therapy
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: true
Specific therapySpecific therapy: Details of specific therapies within a category.
Sytemic therapy typeSytemic therapy type: The type of systemic therapy.
  •  Coded Text
    • Glucocorticosteroids 
    • CsA 
    • MTX 
    • AZA 
    • MMF 
    • MPS 
    • IVIG 
  •  Text
RouteRoute: The systemic therapy route.
  • Oral 
  • Intramuscular 
  • Intravenous 
Start dateStart date: The start date of the therapy.
Duration of therapyDuration of therapy: The duration of the therapy.
>=P0D
Units:
  • Year
  • Month
  • Week
  • Day
  • Hour
  • Minute
Frequency of therapyFrequency of therapy: The frequency of the therapy.
>=0; >=0
Units:
  • /d
  • /wk
  • /mo
  • /yr
  • {QUALIFIED REAL/TIME}
EffectivenessEffectiveness: An estimate of the effectivemess of the therapy.
  •  Coded Text
    • Good 
    • Moderate 
    • None (primary) 
    • None (secondary) 
  •  Text
Reason for stoppingReason for stopping: The reason for stopping the therapy.
  •  Coded Text
    • Sanata 
    • Adverse event 
    • Ineffective 
  •  Text
PhototherapyPhototherapy: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Phototherapy 
Default value: Phototherapy
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: true
Specific therapySpecific therapy: Details of specific therapies within a category.
PhototherapyPhototherapy: Details of phototherapy.
Phototherapy typePhototherapy type: The type of phototherapy.
  • UVA-1 
  • NB-UVB 
Maximum doseMaximum dose: The maximum dose of phototherapy.
Cumulative doseCumulative dose: The cumulative dose of phototherapy.
Start dateStart date: The start date of the therapy.
Duration of therapyDuration of therapy: The duration of the therapy.
>=P0D
Units:
  • Year
  • Month
  • Week
  • Day
  • Hour
  • Minute
Frequency of therapyFrequency of therapy: The frequency of the therapy.
>=0; >=0
Units:
  • /d
  • /wk
  • /mo
  • /yr
  • {QUALIFIED REAL/TIME}
EffectivenessEffectiveness: An estimate of the effectivemess of the therapy.
  •  Coded Text
    • Good 
    • Moderate 
    • None (primary) 
    • None (secondary) 
  •  Text
Reason for stoppingReason for stopping: The reason for stopping the therapy.
  •  Coded Text
    • Sanata 
    • Adverse event 
    • Ineffective 
  •  Text
Topical therapyTopical therapy: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Topical therapy 
Default value: Topical therapy
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: true
Specific therapySpecific therapy: Details of specific therapies within a category.
Topical therapyTopical therapy: Details of topical therapy.
Topical therapy typeTopical therapy type: The type of topical therapy.
  • Corticosteroïd 
  • Protopic 
  • Elidel 
  • Coal tar 
PotencyPotency: Potency of topical therapy.
  • II 
  • III 
  • IV 
  • Not applicable 
Start dateStart date: The start date of the therapy.
Duration of therapyDuration of therapy: The duration of the therapy.
>=P0D
Units:
  • Year
  • Month
  • Week
  • Day
  • Hour
  • Minute
Frequency of therapyFrequency of therapy: The frequency of the therapy.
>=0; >=0
Units:
  • /d
  • /wk
  • /mo
  • /yr
EffectivenessEffectiveness: An estimate of the effectivemess of the therapy.
  •  Coded Text
    • Good 
    • Moderate 
    • None (primary) 
    • None (secondary) 
  •  Text
Reason for stoppingReason for stopping: The reason for stopping the therapy.
  •  Coded Text
    • Sanata 
    • Adverse event 
    • Ineffective 
  •  Text
AntihistaminesAntihistamines: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Antihistamines 
Default value: Antihistamines
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: true
Specific therapySpecific therapy: Details of specific therapies within a category.
Antihistamine typeAntihistamine type: Type of antihistamine.
  •  Coded Text
    • Aerius 
    • Atarax 
    • Xyzal 
    • Zyrtec 
    • Fenistil 
    • Nedeltran 
  •  Text
DoseDose: The dose of antihistamines.
Adverse effectsAdverse effects: Adverse effects of antihistamines.
Start dateStart date: The start date of the therapy.
Duration of therapyDuration of therapy: The duration of the therapy.
>=P0D
Units:
  • Year
  • Month
  • Week
  • Day
  • Hour
  • Minute
Frequency of therapyFrequency of therapy: The frequency of the therapy.
>=0; >=0
Units:
  • /d
  • /wk
  • /mo
  • /yr
EffectivenessEffectiveness: An estimate of the effectivemess of the therapy.
  •  Coded Text
    • Good 
    • Moderate 
    • None (primary) 
    • None (secondary) 
  •  Text
Reason for stoppingReason for stopping: The reason for stopping the therapy.
  •  Coded Text
    • Sanata 
    • Adverse event 
    • Ineffective 
  •  Text
EmollientsEmollients: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Emollients 
Default value: Emollients
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: true
AntibioticsAntibiotics: Summarised dermatology therapy for registry use.
Therapy categoryTherapy category: The general category of therapy.
  • Antibiotics 
Default value: Antibiotics
Therapy category used?Therapy category used?: Has the therapy category been used?
Current therapy?Current therapy?: Is this a currently used treatment?
Default value: true
Allergic disordersAllergic disorders: A generic section header which should be renamed in a template to suit a specific clinical context.
Adverse Reaction Risk(FHIR/openEHR)Adverse Reaction Risk(FHIR/openEHR): Risk of harmful or undesirable, physiological response which is unique to an individual and associated with exposure to a substance.
Substances include, but are not limited to: a therapeutic substance administered correctly at an appropriate dosage for the individual; food; material derived from plants or animals; or venom from insect stings.
Optional[{source=openEHR,FHIR}]
Data
Food allergenFood allergen: Identification of a substance, or a class of substances, that is considered to be responsible for the adverse reaction.
The Substance field allows for the use of a either specific substance (for example 'Amoxycillin') or a group or class of substances (for example 'Penicillins'). Duplication in the 'Substance' and 'Specific substance' fields is acceptable if clinically appropriate. It is strongly recommended that both 'Substance' and 'Specific substance' be coded with a terminology capable of triggering decision support, where possible. For example: including but not limited to RxNorm, Snomed CT, DM+D, NDFRT, ICD-9, IDC-10, UNI, ATC and CPT. Plain text should be used only if there is no appropriate terminology available.
Optional[{source=openEHR,FHIR,DAM}]
Reaction eventReaction event: Details about each adverse reaction event linked to exposure to the identified 'Substance'.
Optional[{source=openEHR,FHIR,DAM}]
ManifestationManifestation: Clinical symptoms and/or signs that are observed or associated with the adverse reaction.
Manifestation can be expressed as a single word, phrase or brief description. For example: nausea, rash or no reaction. It is preferable that 'Manifestation' should be coded with a terminology, where possible. The values entered here may be used to display on an application screen as part of a list of adverse reactions, as recommended in the UK NHS CUI guidelines. Terminologies commonly used include, but are not limited to, SNOMED-CT or ICD10.
Optional[{source=FHIR, openEHR,DAM}]
  • Rash around mouth
  • Erythema skin
  • Itch
  • Urticaria
  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Shock / collaps
  • Exacerbation eczema
Duration of reactionDuration of reaction: The total amount of time that the manifestation of the adverse reaction persisted.
Optional[{source=openEHR}]
Initial exposureInitial exposure: Record of the date and/or time of the first exposure to the Substance for this Reaction Event.
Exposure can be more complicated by more than one exposure events leading to a reaction. Further details about the nature of the exposure can be provided by use of additional archetypes in the 'Exposure details' SLOT or as text in the 'Exposure description'.
Optional[{source=FHIR, openEHR,DAM}]
Protocol
Date recordedDate recorded: Date when the propensity/reaction event was recorded or revised.
[Note: FHIR - maps to recordedDate in FHIR.]
Optional[{source=openEHR,FHIR.DAM}]
Supporting clinical record informationSupporting clinical record information: Link to further information about the presentation and findings that exist elsewhere in the health record, including allergy test reports.
For example, presenting symptoms, examination findings, diagnosis etc. [Note: FHIR,DAM: Maps to Sensitivity Test.]
Optional[{source=FHIR, openEHR, DAM}]
Reporting detailsReporting details: Additional structured details required for reporting to regulatory bodies can be provided by inclusion of specific archetypes in this SLOT.
Reaction reported?Reaction reported?: Was the adverse reaction reported to a regulatory body?
Optional[{source=openEHR}]
Report commentReport comment: Additional narrative about the adverse reaction report or reporting process.
For example, the reason for non-reporting.
Optional[{source=openEHR}]
Adverse reaction reportAdverse reaction report: Link to an adverse reaction Report sent to a regulatory body.
Optional[{source=openEHR}]
FHIR record provenanceFHIR record provenance: FHIR elements that are carried implicitly in the openEHR reference model.
SubjectSubject: The patient who has the allergy or intolerance.
openEHR: implicit in the reference model ENTRY/subject.
Optional[{source=FHIR}]
IdentifierIdentifier: External Ids for this item.
openEHR: implicit in the reference model ENTRY/id.
Optional[{source=FHIR}]
RecorderRecorder: Indicates who has responsibility for the record.
openEHR: implicit in the reference model ENTRY/provider.
Optional[{source=FHIR}]
Problem/DiagnosisProblem/Diagnosis: An issue or obstacle which adversely impacts on the physical, mental and/or social well-being of an individual. The definition of a problem is deliberately kept rather loose and inclusive of a formal biomedical diagnosis so as to capture any real or perceived concerns that may adversely affect an individual's wellbeing to any degree.
Data
Problem/DiagnosisProblem/Diagnosis: Identification of the index problem, issue or diagnosis.
  • Allergic rhinoconjuntivitis
  • Asthma
Protocol
Supporting clinical evidenceSupporting clinical evidence: Useful information on the internet about this condition.
Exclusion of a Problem/DiagnosisExclusion of a Problem/Diagnosis: Positive statement/s about problems or diagnoses that need to be recorded as clinically excluded from the health record at a specific point in time.
Data
Exclusion StatementExclusion Statement: A statement about exclusion of use of known problems or diagnoses in the health record.
For example: "No known significant problems or diagnoses"; or "No evidence of" or "Never diagnosed with" (diabetes).
  • No history of asthma
  • No history of allergic rhinoconjunctivitis
Protocol
Date Last UpdatedDate Last Updated: The date at which the exclusion was last clinically asserted, affirmed or confirmed.
Exclusion of an Adverse ReactionExclusion of an Adverse Reaction: Positive statement/s about adverse reactions that need to be recorded as clinically excluded from the health record at a specific point in time.
Exclusion StatementExclusion Statement: A statement about exclusion of known adverse reactions in the health record.
For example: "No known adverse reactions"; "No known adverse reaction to" (penicillin).
  • No history of food allergies
Date Last UpdatedDate Last Updated: The date at which the exclusion was last clinically asserted, affirmed or confirmed.
Allergy testingAllergy testing: A generic section header which should be renamed in a template to suit a specific clinical context.
PhadiatopPhadiatop: To record the result of a laboratory test which may be used to record a single valued test but will often be specialised or templated to represent multiple value or 'panel' tests. This archetype also acts as the parent for specialisations appropriate for more specific laboratory tests microbiology, histopathology.
Any eventAny event: Any event.
Test nameTest name: Specific identifier for this lab test. e.g. Full blood count , blood glucose, urine microbiology. May equate to the result name for a single value result. Commonly a coded term e.g from LOINC or SNOMED-CT.
Default value: Phadiatop
PhadiatopPhadiatop: The result of the test.
RAST Test (inhalation)RAST Test (inhalation): To record the result of a laboratory test which may be used to record a single valued test but will often be specialised or templated to represent multiple value or 'panel' tests. This archetype also acts as the parent for specialisations appropriate for more specific laboratory tests microbiology, histopathology.
Any eventAny event: Any event.
Test nameTest name: Specific identifier for this lab test. e.g. Full blood count , blood glucose, urine microbiology. May equate to the result name for a single value result. Commonly a coded term e.g from LOINC or SNOMED-CT.
Default value: RAST Test (inhalation)
Test statusTest status: The status of the lab test as a whole.
  • Final 
  • Never performed 
TreesTrees: The result of the test.
Herbs/ spicesHerbs/ spices: The result of the test.
FungusFungus: The result of the test.
House dust miteHouse dust mite: The result of the test.
Grass pollenGrass pollen: The result of the test.
Cat danderCat dander: The result of the test.
Dog danderDog dander: The result of the test.
AspergillusAspergillus: The result of the test.
ResultResult: The result of the test.
Prick testPrick test: To record the result of a laboratory test which may be used to record a single valued test but will often be specialised or templated to represent multiple value or 'panel' tests. This archetype also acts as the parent for specialisations appropriate for more specific laboratory tests microbiology, histopathology.
Any eventAny event: Any event.
Test nameTest name: Specific identifier for this lab test. e.g. Full blood count , blood glucose, urine microbiology. May equate to the result name for a single value result. Commonly a coded term e.g from LOINC or SNOMED-CT.
Default value: Prick test
Prick testPrick test: The result of the test.
IgE test (food)IgE test (food): To record the result of a laboratory test which may be used to record a single valued test but will often be specialised or templated to represent multiple value or 'panel' tests. This archetype also acts as the parent for specialisations appropriate for more specific laboratory tests microbiology, histopathology.
Any eventAny event: Any event.
Test nameTest name: Specific identifier for this lab test. e.g. Full blood count , blood glucose, urine microbiology. May equate to the result name for a single value result. Commonly a coded term e.g from LOINC or SNOMED-CT.
Default value: IgE Test (food)
Chicken proteinChicken protein: The result of the test.
Milk proteinMilk protein: The result of the test.
PeanutPeanut: The result of the test.
CodCod: The result of the test.
WheatWheat: The result of the test.
SojaSoja: The result of the test.
ResultResult: The result of the test.
Epicutaneous skin testEpicutaneous skin test: To record the result of a laboratory test which may be used to record a single valued test but will often be specialised or templated to represent multiple value or 'panel' tests. This archetype also acts as the parent for specialisations appropriate for more specific laboratory tests microbiology, histopathology.
Any eventAny event: Any event.
Test nameTest name: Specific identifier for this lab test. e.g. Full blood count , blood glucose, urine microbiology. May equate to the result name for a single value result. Commonly a coded term e.g from LOINC or SNOMED-CT.
Default value: Epicutaneous skin test
lanolin alcohollanolin alcohol: The result of the test.
cetyl alcoholcetyl alcohol: The result of the test.
stearylalcoholstearylalcohol: The result of the test.
lanette wax/sera lanettelanette wax/sera lanette: The result of the test.
cetomacrogol was/ sera cetomacrogoliscetomacrogol was/ sera cetomacrogolis: The result of the test.
amerchol L101amerchol L101: The result of the test.
ResultResult: The result of the test.
woolalcohols 30% mixwoolalcohols 30% mix: The result of the test.
perfume mix Iperfume mix I: The result of the test.
perfume mix IIperfume mix II: The result of the test.
cocamidopropylbetainecocamidopropylbetaine: The result of the test.
Lab valuesLab values: A generic section header which should be renamed in a template to suit a specific clinical context.
Laboratory testLaboratory test: To record the result of a laboratory test which may be used to record a single valued test but will often be specialised or templated to represent multiple value or 'panel' tests. This archetype also acts as the parent for specialisations appropriate for more specific laboratory tests microbiology, histopathology.
Any eventAny event: Any event.
Test nameTest name: Specific identifier for this lab test. e.g. Full blood count , blood glucose, urine microbiology. May equate to the result name for a single value result. Commonly a coded term e.g from LOINC or SNOMED-CT.
ResultResult: The result of the test.
Outcome measurementsOutcome measurements: A generic section header which should be renamed in a template to suit a specific clinical context.
Investigators Global AssessmentInvestigators Global Assessment: The Investigators Global Assessment (IGA) is a 6 point scale. It is a severity measure intended to provide a clinically meaningful snapshot of atopic dermatitis severity that can be understood by both patients and physicians.
Any eventAny event: Any event.
Data
Investigator Global Assessment scoreInvestigator Global Assessment score: The total IGA score.
A representative area should be utilised as a means to generate this score.
  • 0: Clear 
  • 1: Almost clear 
  • 2: Mild disease 
  • 3: Moderate disease 
  • 4: Severe disease 
  • 5: Very severe disease 
Patients global assessmentPatients global assessment: The patient's global assessment (PGA) is a 6 point scale utilised to enable a patient to describe the severity of their eczema.
Any eventAny event: Any event.
Data
Patient Global Assessment scorePatient Global Assessment score: The total score.
  • 0: Clear 
  • 1: Almost clear 
  • 2: Mild disease 
  • 3: Moderate disease 
  • 4: Severe disease 
  • 5: Very severe disease 
Poem scorePoem score: POEM (Patient-Oriented Eczema Measure).
Any eventAny event: Any event.
Data
Symptom scoreSymptom score: The symptom score.
Symptom nameSymptom name: Symptom experienced by the patient in the past week.
  • Itch 
  • Sleep loss 
  • Weeping 
  • Cracking 
  • Flaking 
  • Dry or rough skin 
FrequencyFrequency: Frequency of the symptom.
  • 0: 0 days 
  • 1: 1-2 days 
  • 2: 3-4 days 
  • 3: 5-6 days 
  • 4: Every day 
Total Poem scoreTotal Poem score: The total Poem score.
The score is the sum of the frequencies with which all of the symptoms are experienced in the past week.
<=28
EASI scoreEASI score: Atopic dermatitis EASI score.
Head and neckHead and neck: The part of the body being assessed.
(Severity index)(Severity index): The level of severity of the symptom for a representative part of the body area.
  • 0: Absent 
  • 1: Mild 
  • 2: Moderate 
  • 3: Severe 
Affected areaAffected area: The extent of the area affected.
  • 0: 1% to 9% 
  • 1: 10% to 29% 
  • 2: 30% to 49% 
  • 3: 50% to 69% 
  • 4: 70% to 89% 
  • 5: 90% to 100% 
Upper limbsUpper limbs: The part of the body being assessed.
(Severity index)(Severity index): The level of severity of the symptom for a representative part of the body area.
  • 0: Absent 
  • 1: Mild 
  • 2: Moderate 
  • 3: Severe 
Affected areaAffected area: The extent of the area affected.
  • 0: 1% to 9% 
  • 1: 10% to 29% 
  • 2: 30% to 49% 
  • 3: 50% to 69% 
  • 4: 70% to 89% 
  • 5: 90% to 100% 
TrunkTrunk: The part of the body being assessed.
(Severity index)(Severity index): The level of severity of the symptom for a representative part of the body area.
  • 0: Absent 
  • 1: Mild 
  • 2: Moderate 
  • 3: Severe 
Affected areaAffected area: The extent of the area affected.
  • 0: 1% to 9% 
  • 1: 10% to 29% 
  • 2: 30% to 49% 
  • 3: 50% to 69% 
  • 4: 70% to 89% 
  • 5: 90% to 100% 
Lower limbsLower limbs: The part of the body being assessed.
(Severity index)(Severity index): The level of severity of the symptom for a representative part of the body area.
  • 0: Absent 
  • 1: Mild 
  • 2: Moderate 
  • 3: Severe 
Affected areaAffected area: The extent of the area affected.
  • 0: 1% to 9% 
  • 1: 10% to 29% 
  • 2: 30% to 49% 
  • 3: 50% to 69% 
  • 4: 70% to 89% 
  • 5: 90% to 100% 
Total EASI scoreTotal EASI score: The total EASI score.
0..72
SCORAD scoreSCORAD score: SCORAD - atopic dematitis severity score.
Data
Affected areaAffected area: Extent of affected area.
  • Percent
Intensity of specific lesionsIntensity of specific lesions: The intensity of typical specific lesions.
(Specific lesion)(Specific lesion): The level of intensity of a symptom.
  • 0: Absent 
  • 1: Mild 
  • 2: Moderate 
  • 3: Severe 
Sleep disturbanceSleep disturbance: A subjective observation by an individual about departure from normal function and which may indicate the presence of disease or abnormality. Either self-recorded or recorded on the behalf of a patient by a clinician.
Symptom nameSymptom name: The symptom experienced.
Coding with an external terminology is preferred, where possible.
Default value: Sleep disturbance
Visual Analogue ScoreVisual Analogue Score: A score from 0 (not present) to 10 (as bad as it could be).
0..10
ItchingItching: A subjective observation by an individual about departure from normal function and which may indicate the presence of disease or abnormality. Either self-recorded or recorded on the behalf of a patient by a clinician.
Symptom nameSymptom name: The symptom experienced.
Coding with an external terminology is preferred, where possible.
Default value: Itching
Visual Analogue ScoreVisual Analogue Score: A score from 0 (not present) to 10 (as bad as it could be).
0..10
Total SCORAD scoreTotal SCORAD score: The total SCORAD score.
Total intensity gradeTotal intensity grade: The total score expressed as a set of grades.
  • Mild 
  • Moderate 
  • Severe 
Adverse eventsAdverse events: A generic section header which should be renamed in a template to suit a specific clinical context.
Medication safety eventMedication safety event: Summary of a patient safety event associated with medication for reporting purposes.
Safety event typeSafety event type: The type of event reported.
Value set: terminology:SafetyEventType
MEDRA classificationMEDRA classification: The category of event reported using MedDRA classification.
Value set: ac0001
DateTime of event onsetDateTime of event onset: The date and/or time that the adverse event took place.
Description of eventDescription of event: A narrative description of the medication safety event.
Medications involvedMedications involved: The medicine, vaccine or other therapetic good being ordered, administered to or used by the subject
Medications administeredMedications administered: Medications administered is used to enter wrongly administered drug for Safety event type *at0254 Pacient dobil drugo zdravilo od predpisanega* Wrong drug administered to a patient
Conclusion and managementConclusion and management: A generic section header which should be renamed in a template to suit a specific clinical context.
ConclusionConclusion: Narrative summary or overview about a patient, specifically from the perspective of a healthcare provider, and with or without associated interpretations.
SynopsisSynopsis: The summary, assessment, conclusions or evaluation of the clinical findings.